<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Vet Intern Med</journal-id><journal-id journal-id-type="iso-abbrev">J. Vet. Intern. Med</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1939-1676</journal-id><journal-id journal-id-type="publisher-id">JVIM</journal-id><journal-title-group><journal-title>Journal of Veterinary Internal Medicine</journal-title></journal-title-group><issn pub-type="ppub">0891-6640</issn><issn pub-type="epub">1939-1676</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25776251</article-id><article-id pub-id-type="pmc">4895498</article-id><article-id pub-id-type="doi">10.1111/jvim.12563</article-id><article-id pub-id-type="publisher-id">JVIM12563</article-id><article-categories><subj-group subj-group-type="overline"><subject>Standard Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Standard Articles</subject></subj-group></article-categories><title-group><article-title>A Prospective, Randomized, Blinded, Placebo&#x02010;Controlled Pilot Study on the Effect of <italic>Enterococcus faecium</italic> on Clinical Activity and Intestinal Gene Expression in Canine Food&#x02010;Responsive Chronic Enteropathy</article-title><alt-title alt-title-type="left-running-head">Schmitz et&#x000a0;al</alt-title></title-group><contrib-group><contrib id="jvim12563-cr-0001" contrib-type="author" corresp="yes"><name><surname>Schmitz</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="jvim12563-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jvim12563-cr-0002" contrib-type="author"><name><surname>Glanemann</surname><given-names>B.</given-names></name><xref ref-type="aff" rid="jvim12563-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jvim12563-cr-0003" contrib-type="author"><name><surname>Garden</surname><given-names>O.A.</given-names></name><xref ref-type="aff" rid="jvim12563-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jvim12563-cr-0004" contrib-type="author"><name><surname>Brooks</surname><given-names>H.</given-names></name><xref ref-type="aff" rid="jvim12563-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="jvim12563-cr-0005" contrib-type="author"><name><surname>Chang</surname><given-names>Y.M.</given-names></name><xref ref-type="aff" rid="jvim12563-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="jvim12563-cr-0006" contrib-type="author"><name><surname>Werling</surname><given-names>D.</given-names></name><xref ref-type="aff" rid="jvim12563-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="jvim12563-cr-0007" contrib-type="author"><name><surname>Allenspach</surname><given-names>K.</given-names></name><xref ref-type="aff" rid="jvim12563-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="jvim12563-aff-0001"><label><sup>1</sup></label><named-content content-type="organisation-division">Department of Clinical Sciences and Services</named-content><institution>Royal Veterinary College</institution><institution>University of London</institution><named-content content-type="city">North Mymms</named-content><named-content content-type="city">Hertfordshire</named-content><country country="GB">UK</country></aff><aff id="jvim12563-aff-0002"><label><sup>2</sup></label><named-content content-type="organisation-division">Department of Pathology and Pathogen Biology</named-content><institution>Royal Veterinary College</institution><institution>University of London</institution><named-content content-type="city">North Mymms</named-content><named-content content-type="city">Hertfordshire</named-content><country country="GB">UK</country></aff><aff id="jvim12563-aff-0003"><label><sup>3</sup></label><named-content content-type="organisation-division">Research Support Office</named-content><institution>Royal Veterinary College</institution><institution>University of London</institution><named-content content-type="city">North Mymms</named-content><named-content content-type="city">Hertfordshire</named-content><country country="GB">UK</country></aff><author-notes><corresp id="correspondenceTo"><label>*</label>Corresponding author: Silke Schmitz, Small Animal Hospital, Department Internal Medicine, Justus&#x02010;Liebig University, Frankfurter Str. 126, 35392, Giessen, Germany; e&#x02010;mail: <email>Silke.Schmitz@vetmed.uni-giessen.de</email></corresp></author-notes><pub-date pub-type="epub"><day>16</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2015</year></pub-date><volume>29</volume><issue>2</issue><issue-id pub-id-type="doi">10.1111/jvim.2015.29.issue-2</issue-id><fpage>533</fpage><lpage>543</lpage><history><date date-type="received"><day>18</day><month>9</month><year>2014</year></date><date date-type="rev-recd"><day>07</day><month>1</month><year>2015</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2015</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2015 American College of Veterinary Internal Medicine <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2015 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.</copyright-statement><license license-type="creativeCommonsBy-nc"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution&#x02010;NonCommercial</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:JVIM-29-533.pdf"/><abstract id="jvim12563-abs-0001"><sec id="jvim12563-sec-0001"><title>Background</title><p>Canine chronic enteropathies (<styled-content style="fixed-case">CE</styled-content>) are believed to be caused by an aberrant immune response towards the intestinal microbiome. Administration of probiotics can alleviate colitis in people. In vitro effects of the probiotic <italic>Enterococcus faecium </italic>
<styled-content style="fixed-case">NCIMB</styled-content> 10415 E1707 (<styled-content style="fixed-case">EF</styled-content>) previously have been evaluated using canine cells (e.g., whole blood, intestinal biopsies), but data on in&#x000a0;vivo efficacy are lacking.</p></sec><sec id="jvim12563-sec-0002"><title>Hypothesis/Objectives</title><p>Administration of <styled-content style="fixed-case">EF</styled-content> to dogs with food&#x02010;responsive <styled-content style="fixed-case">CE</styled-content> will improve clinical outcome and decrease the intestinal inflammatory profile.</p></sec><sec id="jvim12563-sec-0003"><title>Animals</title><p>Dogs diagnosed with <styled-content style="fixed-case">CE</styled-content> were prospectively recruited to receive a hydrolyzed elimination diet plus either a synbiotic product containing <styled-content style="fixed-case">EF</styled-content> or placebo for 6&#x000a0;weeks. Both veterinary staff and owners were blinded to the treatment.</p></sec><sec id="jvim12563-sec-0004"><title>Methods</title><p>Clinical severity index (<styled-content style="fixed-case">CCECAI</styled-content>), clinicopathological data and gene expression using intestinal biopsies (<styled-content style="fixed-case">TLR</styled-content>2/4/5/9, <styled-content style="fixed-case">IL</styled-content>&#x02010;17A, <styled-content style="fixed-case">IL</styled-content>&#x02010;22, <styled-content style="fixed-case">IL</styled-content>&#x02010;23p19, <styled-content style="fixed-case">RORC</styled-content>,<styled-content style="fixed-case"> IL</styled-content>&#x02010;2, <styled-content style="fixed-case">IL</styled-content>&#x02010;12p35, <styled-content style="fixed-case">TNF</styled-content>&#x003b1;, <styled-content style="fixed-case">IL</styled-content>&#x02010;4, <styled-content style="fixed-case">IFN</styled-content>y, <styled-content style="fixed-case">IL</styled-content>&#x02010;10, <styled-content style="fixed-case">TGF</styled-content>&#x003b2;, <styled-content style="fixed-case">IL</styled-content>&#x02010;1&#x003b2;, <styled-content style="fixed-case">IL</styled-content>&#x02010;18, <styled-content style="fixed-case">NLRP</styled-content>3, casp&#x02010;1, <styled-content style="fixed-case">TFF</styled-content>1, <styled-content style="fixed-case">TFF</styled-content>3 and <styled-content style="fixed-case">PPAR</styled-content>y) before and after 6&#x000a0;weeks of treatment were analyzed using linear mixed modeling.</p></sec><sec id="jvim12563-sec-0005"><title>Results</title><p>Of the 45 cases recruited, 12 finished the clinical trial. Seven received the synbiotic and 5 the placebo product. There was no difference between groups or treatments regarding clinical efficacy, histology scores or expression of any of the investigated genes.</p></sec><sec id="jvim12563-sec-0006"><title>Conclusions and clinical importance</title><p>Standard dietary treatment induced rapid clinical response in all cases. Because the study was underpowered, it was not possible to determine whether or not <styled-content style="fixed-case">EF</styled-content> had an additional effect within the time period of 6&#x000a0;weeks.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jvim12563-kwd-0001">diarrhea</kwd><kwd id="jvim12563-kwd-0002">dog</kwd><kwd id="jvim12563-kwd-0003">inflammatory bowel disease</kwd><kwd id="jvim12563-kwd-0004">probiotics</kwd></kwd-group><funding-group><award-group><funding-source>BBSRC with a studentship with Probiotics International Ltd., Somerset, UK</funding-source></award-group></funding-group><counts><page-count count="11"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>jvim12563</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March/April 2015</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.8.9 mode:remove_FC converted:06.05.2016</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="jvim12563-ntgp-0001"><fn id="jvim12563-note-0001"><p>The work presented in this manuscript was performed at the Royal Veterinary College, London, UK.</p></fn><fn id="jvim12563-note-0002"><p>This paper was presented as an oral abstract at the ECVIM Congress 2013 in Liverpool, UK.</p></fn></fn-group></notes></front><body><def-list list-content="abbreviations" id="jvim12563-dl-0001"><title>Abbreviations</title><def-item><term>ACTH</term><def><p>adrenocorticotropic hormone</p></def></def-item><def-item><term>ARD</term><def><p>antibiotic&#x02010;responsive disease</p></def></def-item><def-item><term>ASPA</term><def><p>animal scientific procedure act of the United Kingdom</p></def></def-item><def-item><term>casp&#x02010;1</term><def><p>caspase 1</p></def></def-item><def-item><term>CCECAI</term><def><p>canine chronic enteropathy clinical activity index</p></def></def-item><def-item><term>CE</term><def><p>chronic enteropathy</p></def></def-item><def-item><term>cPL</term><def><p>canine pancreatic lipase</p></def></def-item><def-item><term>EF</term><def><p>enterococcus faecium</p></def></def-item><def-item><term>FOS</term><def><p>fructo&#x02010;oligosaccharides</p></def></def-item><def-item><term>FoxP3</term><def><p>forkhead&#x02010;box protein 3</p></def></def-item><def-item><term>FRD</term><def><p>food&#x02010;responsive disease</p></def></def-item><def-item><term>GIT</term><def><p>gastrointestinal tract</p></def></def-item><def-item><term>IFN&#x003b3;</term><def><p>interferon gamma</p></def></def-item><def-item><term>IL</term><def><p>interleukin</p></def></def-item><def-item><term>MAPK</term><def><p>mitogen&#x02010;activated pyruvate kinase</p></def></def-item><def-item><term>NF&#x003ba;B</term><def><p>nuclear factor kappa B</p></def></def-item><def-item><term>NLRP3</term><def><p>nod&#x02010;like receptor with pyrin domain 3</p></def></def-item><def-item><term>PI3K</term><def><p>phosphatidyl&#x02010;Inositol 3 kinase</p></def></def-item><def-item><term>PPAR&#x003b3;</term><def><p>peroxisome proliferator&#x02010;activated receptor gamma</p></def></def-item><def-item><term>PRR</term><def><p>pathogen&#x02010;recognition receptor</p></def></def-item><def-item><term>qPCR</term><def><p>quantitative reverse&#x02010;transcription real&#x02010;time polymerase chain reaction</p></def></def-item><def-item><term>RIN</term><def><p>RNA integrity number</p></def></def-item><def-item><term>RORC</term><def><p>retinoic acid receptor&#x02010;related orphan receptor C</p></def></def-item><def-item><term>RVC</term><def><p>Royal Veterinary College, London, United Kingdom</p></def></def-item><def-item><term>SRD</term><def><p>steroid&#x02010;responsive disease</p></def></def-item><def-item><term>TFF</term><def><p>trefoil factor</p></def></def-item><def-item><term>TGF&#x003b2;</term><def><p>transforming&#x02010;growth factor beta</p></def></def-item><def-item><term>Th cells</term><def><p>T helper lymphocyte cells</p></def></def-item><def-item><term>TLI</term><def><p>trypsin&#x02010;like immunoreactivity</p></def></def-item><def-item><term>TLR</term><def><p>toll&#x02010;like receptor</p></def></def-item><def-item><term>TNF&#x003b1;</term><def><p>tumor&#x02010;necrosis factor alpha</p></def></def-item><def-item><term>Tregs</term><def><p>regulatory T&#x02010;lymphocytes</p></def></def-item><def-item><term>WSAVA</term><def><p>World Small Animal Veterinary Association</p></def></def-item></def-list><p>Canine chronic enteropathies (CE) are a group of inflammatory intestinal diseases of unknown cause.<xref rid="jvim12563-bib-0001" ref-type="ref">1</xref>, <xref rid="jvim12563-bib-0002" ref-type="ref">2</xref> They usually are defined by response to treatment as food&#x02010;responsive disease (FRD), antibiotic&#x02010;responsive disease (ARD) and (idiopathic) inflammatory bowel disease (IBD), with the latter also being termed steroid&#x02010;responsive disease (SRD).<xref rid="jvim12563-bib-0002" ref-type="ref">2</xref>, <xref rid="jvim12563-bib-0003" ref-type="ref">3</xref> All of these syndromes manifest in variable degrees and combinations of gastrointestinal signs (e.g., diarrhea, vomiting, weight loss, changes in appetite).</p><p>Because microbiome changes are consistently found in dogs with CE,<xref rid="jvim12563-bib-0004" ref-type="ref">4</xref>, <xref rid="jvim12563-bib-0005" ref-type="ref">5</xref>, <xref rid="jvim12563-bib-0006" ref-type="ref">6</xref> modification of the intestinal microbiome in the form of pre&#x02010; and pro&#x02010;biotics seems to be an interesting treatment option. Several studies have shown that probiotics can influence key biological signaling pathways in immune cells such as NF&#x003ba;B, MAPK, Akt/PI3K and PPAR&#x003b3;.<xref rid="jvim12563-bib-0007" ref-type="ref">7</xref>, <xref rid="jvim12563-bib-0008" ref-type="ref">8</xref>, <xref rid="jvim12563-bib-0009" ref-type="ref">9</xref>, <xref rid="jvim12563-bib-0010" ref-type="ref">10</xref>, <xref rid="jvim12563-bib-0011" ref-type="ref">11</xref> In humans with&#x000a0;IBD and mice with experimental colitis, respectively, administration of probiotics has been shown to alleviate intestinal inflammation, prevent relapse or both by induction of a more tolerant microenvironment.<xref rid="jvim12563-bib-0012" ref-type="ref">12</xref>, <xref rid="jvim12563-bib-0013" ref-type="ref">13</xref>, <xref rid="jvim12563-bib-0014" ref-type="ref">14</xref>
</p><p>Knowledge about the usefulness of probiotics in CE in dogs is limited. Only two studies have evaluated the <italic>in&#x000a0;vivo</italic> effect of probiotics in dogs with chronic gastrointestinal diseases.<xref rid="jvim12563-bib-0015" ref-type="ref">15</xref>, <xref rid="jvim12563-bib-0016" ref-type="ref">16</xref> One used a combination of different lactobacilli in dogs with FRD compared to placebo (diet only),<xref rid="jvim12563-bib-0015" ref-type="ref">15</xref> the other a commercially available product for humans, which contains eight different strains of bacteria (lactobacilli, bifidobacteria, streptococci) in comparison to a combination treatment consisting of metronidazole and prednisolone.<xref rid="jvim12563-bib-0016" ref-type="ref">16</xref> In the FRD study, all dogs improved clinically after treatment, but intestinal mucosal cytokine patterns were not correlated with clinical outcome or probiotic supplementation. In the second study, all dogs also improved clinically, but only in&#x000a0;the group treated with probiotics was an increase in FoxP3 positive regulatory T&#x02010;lymphocytes (Tregs) as well as an increase in the supposedly protective <italic>Faecalibacterium prausnitzii</italic> in fecal samples observed.<xref rid="jvim12563-bib-0005" ref-type="ref">5</xref>, <xref rid="jvim12563-bib-0017" ref-type="ref">17</xref>
</p><p>
<italic>Enterococcus faecium</italic> NCIMB 10415 E1707 (EF) is commercially available as a probiotic or synbiotic for small animals both in Europe and in the USA (the US strain is SF68). The strain has shown good properties regarding survival in the upper gastrointestinal tract (GIT),<xref rid="jvim12563-bib-0018" ref-type="ref">18</xref> adhesion to canine intestinal mucus and persistence in fecal samples,<xref rid="jvim12563-bib-0019" ref-type="ref">19</xref> but has not been tested extensively for its immunomodulatory functions. No information regarding the efficacy of this specific probiotic in dogs with CE is available.</p><p>The aim of the present work was to assess the clinical benefit (as measured by the canine chronic enteropathy clinical activity index CCECAI<xref rid="jvim12563-bib-0001" ref-type="ref">1</xref>) of treatment with a synbiotic product (containing EF)<xref ref-type="fn" rid="jvim12563-note-1001">1</xref> in dogs with FRD. In addition, selected clinicopathological data, intestinal endoscopic and histology scores and mucosal gene expression for a variety of genes associated with microbial recognition and modulation of the immune system in the intestine were investigated before and after treatment to assess if EF can induce a more anti&#x02010;inflammatory environment.</p><sec id="jvim12563-sec-0008"><title>Materials and Methods</title><sec id="jvim12563-sec-0009"><title>Conduct of a Prospective, Blinded, Placebo&#x02010;Controlled Clinical Trial</title><sec id="jvim12563-sec-0010"><title>Ethical Approvals and Products Used</title><p>The clinical trial was approved by the RVC's Ethics and Welfare Committee (ASPA number 70/7393) and conducted between June 2010 and May 2013. The synbiotic used contained 1&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>&#x000a0;cfu EF NCIMB 10415 E1707, FOS and gum Arabic<xref ref-type="fn" rid="jvim12563-note-1001">1</xref>. The placebo consisted of an identical capsule containing maltodextran.</p></sec><sec id="jvim12563-sec-0011"><title>Inclusion and Exclusion Criteria</title><p>Dogs with a history typical for chronic enteropathy (&#x02265;3&#x000a0;weeks of vomiting, diarrhea or both, with or without weight loss) were included. The diagnosis of chronic enteropathy was confirmed based on established criteria (no clinically relevant abnormalities on routine hematology, serum biochemistry; trypsin&#x02010;like immunoreactivity [TLI], canine pancreatic lipase [cPL] and adrenocorticotropic hormone [ACTH]&#x02010;stimulation test results within the reference range; no abnormalities on abdominal imaging [radiographs, abdominal ultrasound examination or both]). Histopathologic findings of intestinal mucosal biopsies had to show lymphoplasmacytic, eosinophilic or mixed inflammation with or without architectural changes.<xref rid="jvim12563-bib-0020" ref-type="ref">20</xref>, <xref rid="jvim12563-bib-0021" ref-type="ref">21</xref> Exclusion criteria were the presence of concurrent diseases or treatment with antimicrobials, anti&#x02010;inflammatory drugs or both 7&#x000a0;days before presentation.</p></sec><sec id="jvim12563-sec-0012"><title>Study Design</title><p>Dogs were seen at three separate visits: visit 1 (recruitment), visit 2 (14&#x000a0;&#x000b1;&#x000a0;3&#x000a0;days after starting the trial medication) and visit 3 (42&#x000a0;&#x000b1;&#x000a0;3&#x000a0;days after starting the trial medication; see Fig&#x000a0;<xref rid="jvim12563-fig-0001" ref-type="fig">1</xref>). The procedures performed at each visit are listed in Table&#x000a0;<xref rid="jvim12563-tbl-0001" ref-type="table-wrap">1</xref>. Patients were randomized (using random permutated blocks of n&#x000a0;=&#x000a0;12 that had been designed before the start of the study<xref ref-type="fn" rid="jvim12563-note-1002">2</xref>) to receive either the synbiotic EF product or placebo in conjunction with a hydrolyzed protein diet<xref ref-type="fn" rid="jvim12563-note-1003">3</xref>. All members of staff involved in the trial (apart from the study monitor, a head nurse) were blinded to the dogs' medications.</p><table-wrap id="jvim12563-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Outline and procedures for each dog at each visit of the clinical trial</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Visit</th><th align="left" valign="top" rowspan="1" colspan="1">History</th><th align="left" valign="top" rowspan="1" colspan="1">PE</th><th align="left" valign="top" rowspan="1" colspan="1">CCECAI</th><th align="left" valign="top" rowspan="1" colspan="1">CBC/BC</th><th align="left" valign="top" rowspan="1" colspan="1">UA</th><th align="left" valign="top" rowspan="1" colspan="1">TLI/cPLI</th><th align="left" valign="top" rowspan="1" colspan="1">Folate/ cobalamin</th><th align="left" valign="top" rowspan="1" colspan="1">ACTH stim</th><th align="left" valign="top" rowspan="1" colspan="1">Faecal</th><th align="left" valign="top" rowspan="1" colspan="1">Endoscopy and biopsy</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">Only albumin</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">X</td></tr></tbody></table><table-wrap-foot><fn id="jvim12563-note-0003"><p>Visit 1&#x000a0;=&#x000a0;before start of treatment, visit 2&#x000a0;=&#x000a0;2&#x000a0;weeks after start of treatment for food&#x02010;responsive chronic enteropathy with either Enterococcus faecium or placebo, visit 3&#x000a0;=&#x000a0;6&#x000a0;weeks after start of treatment. PE, physical exam; CCECAI, canine chronic enteropathy clinical activity index; CBC, complete blood count; BC, serum biochemistry; UA, urinalysis; ACTH stim, adrenocorticotropin stimulation test; faecal, faecal flotation/sedimentation.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><fig fig-type="Figure" xml:lang="en" id="jvim12563-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Outline of the clinical trial. Dogs were seen at three separate visits: Visit (V) 1&#x000a0;=&#x000a0;recruitment and diagnosis, V2&#x000a0;=&#x000a0;after 2&#x000a0;weeks of treatment with either Enterococcus faecium or placebo, V3&#x000a0;=&#x000a0;after 6&#x000a0;weeks of treatment. During the duration of the trial dogs were all fed the same hydrolysed protein diet.</p></caption><graphic id="nlm-graphic-1" xlink:href="JVIM-29-533-g001"/></fig></sec><sec id="jvim12563-sec-0013"><title>Assessment of Clinical Severity</title><p>Clinical severity was assessed using the CCECAI at all three visits.<xref rid="jvim12563-bib-0001" ref-type="ref">1</xref>
</p></sec></sec><sec id="jvim12563-sec-0014"><title>Endoscopy and Endoscopic Scoring of Lesions</title><p>Gastroduodenoscopy and colonoscopy were performed in all dogs according to standard procedures. Macroscopic endoscopic scoring was performed using the World Small Animal Veterinary Association (WSAVA) approved endoscopic examination report.<xref rid="jvim12563-bib-0020" ref-type="ref">20</xref> Multiple biopsies (15&#x02013;20) from the duodenum and colon were taken with a single&#x02010;use endoscopic biopsy forceps, and 10&#x02013;15 from each site were transferred immediately into 2% neutral&#x02010;buffered formalin. The remaining biopsies (minimum of 2) were transferred to RNAlater<xref ref-type="fn" rid="jvim12563-note-1004">4</xref> , stored at 4&#x000b0;C for 24&#x000a0;h and then at &#x02212;80&#x000b0;C until further processing.</p></sec><sec id="jvim12563-sec-0015"><title>Histopathology</title><p>Initial histopathological assessment was performed at the pathology department of the RVC as part of the routine diagnostic procedure. After finalizing the study, all slides were reviewed by 1 of the authors (HB), and WSAVA standardized classification was applied to all slides.<xref rid="jvim12563-bib-0020" ref-type="ref">20</xref>, <xref rid="jvim12563-bib-0021" ref-type="ref">21</xref> As described previously,<xref rid="jvim12563-bib-0022" ref-type="ref">22</xref> 9 histologic variables, five representing morphological changes and four representing inflammatory changes were scored as absent&#x000a0;=&#x000a0;0, mild&#x000a0;=&#x000a0;1, moderate&#x000a0;=&#x000a0;2, or severe&#x000a0;=&#x000a0;3 according to the WSAVA guidelines.<xref rid="jvim12563-bib-0020" ref-type="ref">20</xref>, <xref rid="jvim12563-bib-0021" ref-type="ref">21</xref> The total histology score was recorded. At this stage of histologic analysis, HB was blinded to original diagnosis, visit number and treatment group.</p></sec><sec id="jvim12563-sec-0016"><title>Gene Expression from Intestinal Tissues</title><sec id="jvim12563-sec-0017"><title>RNA Extraction and cDNA Synthesis</title><p>A single biopsy stored in RNAlater was thawed and homogenized in lysis buffer<xref ref-type="fn" rid="jvim12563-note-1005">5</xref> using 5&#x000a0;mm stainless steel beads<xref ref-type="fn" rid="jvim12563-note-1005">5</xref> and a tissue grinder<xref ref-type="fn" rid="jvim12563-note-1006">6</xref>. Total RNA was extracted using a commercial kit<xref ref-type="fn" rid="jvim12563-note-1007">7</xref> including an on&#x02010;column DNAse treatment, and eluted in 30&#x000a0;&#x003bc;L nuclease&#x02010;free water. RNA quantity and quality was assessed using an automated analyzer<xref ref-type="fn" rid="jvim12563-note-1008">8</xref>. Reverse transcription of 1&#x000a0;&#x003bc;g of RNA was performed with a cDNA synthesis kit<xref ref-type="fn" rid="jvim12563-note-1009">9</xref>, which uses a mixture of oligo&#x02010;dT and random nonamer primers.</p></sec><sec id="jvim12563-sec-0018"><title>Generation of Positive Controls and Selection of Reference Genes</title><p>Canine sequences for the genes of interest and reference genes were cloned as described before.<xref rid="jvim12563-bib-0023" ref-type="ref">23</xref> Primers were designed based on publically available gene sequences (Genbank, ENSEMBL) using the Primer3 software (see Table&#x000a0;<xref rid="jvim12563-tbl-0002" ref-type="table-wrap">2</xref>).<xref rid="jvim12563-bib-0024" ref-type="ref">24</xref> A total of 16 genes were assessed for stability using suitable software<xref ref-type="fn" rid="jvim12563-note-1010">10</xref> with a commercially available canine reference gene array<xref ref-type="fn" rid="jvim12563-note-1011">11</xref>. Based on these data, four reference genes were selected for canine duodenum and five for the colon, respectively (Table&#x000a0;<xref rid="jvim12563-tbl-0002" ref-type="table-wrap">2</xref>). Primers were optimized using standard PCR<xref ref-type="fn" rid="jvim12563-note-1012">12</xref>. Amplicons were visualized on a 1.5% agarose gel, purified<xref ref-type="fn" rid="jvim12563-note-1013">13</xref> and cloned into a holding vector<xref ref-type="fn" rid="jvim12563-note-1014">14</xref> for subsequent sequencing<xref ref-type="fn" rid="jvim12563-note-1015">15</xref> and for qPCR standards (see below).</p><table-wrap id="jvim12563-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>List of genes investigated by quantitative reverse&#x02010;transcriptase real&#x02010;time PCR with the respective primers used</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Gene</th><th align="left" valign="top" rowspan="1" colspan="1">product size</th><th align="left" valign="top" rowspan="1" colspan="1">Forward primer</th><th align="left" valign="top" rowspan="1" colspan="1">Reverse primer</th><th align="left" valign="top" rowspan="1" colspan="1">Annealing temp</th><th align="left" valign="top" rowspan="1" colspan="1">Accession number</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Casp&#x02010;1</td><td align="left" rowspan="1" colspan="1">253</td><td align="left" rowspan="1" colspan="1">CGACAGACAGCTGGACACAT</td><td align="left" rowspan="1" colspan="1">ATCTGGGCTTTCACATCTGG</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">NM_001003125.1</td></tr><tr><td align="left" rowspan="1" colspan="1">FoxP3</td><td align="left" rowspan="1" colspan="1">550</td><td align="left" rowspan="1" colspan="1">TGG TGC AGT CTC TGG AAC AG</td><td align="left" rowspan="1" colspan="1">GGC CTT TGG CTT CTC TTC TT</td><td align="left" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">NM_001168461.1</td></tr><tr><td align="left" rowspan="1" colspan="1">IFNy</td><td align="left" rowspan="1" colspan="1">353</td><td align="left" rowspan="1" colspan="1">TTCAGCTTTGCGTGATTTTG</td><td align="left" rowspan="1" colspan="1">CTGCAGATCGTTCACAGGAA</td><td align="left" rowspan="1" colspan="1">54.3</td><td align="left" rowspan="1" colspan="1">NM_001003174.1</td></tr><tr><td align="left" rowspan="1" colspan="1">IL&#x02010;10</td><td align="left" rowspan="1" colspan="1">300</td><td align="left" rowspan="1" colspan="1">TCTGTTGCTGCCTGGTCCT</td><td align="left" rowspan="1" colspan="1">TGATGTCTGGGTCGTGGTT</td><td align="left" rowspan="1" colspan="1">54.3</td><td align="left" rowspan="1" colspan="1">NM_001003077.1</td></tr><tr><td align="left" rowspan="1" colspan="1">IL&#x02010;12p35</td><td align="left" rowspan="1" colspan="1">102</td><td align="left" rowspan="1" colspan="1">ATGACGGTCCTGTGCCTTAG</td><td align="left" rowspan="1" colspan="1">CTGCCTCTTGGGATCCATTA</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">NM_001003293.1</td></tr><tr><td align="left" rowspan="1" colspan="1">IL&#x02010;17A</td><td align="left" rowspan="1" colspan="1">166</td><td align="left" rowspan="1" colspan="1">CCGATCTACCTCACCTTGGA</td><td align="left" rowspan="1" colspan="1">TCGCAGAACCAGGATCTCTT</td><td align="left" rowspan="1" colspan="1">60.2</td><td align="left" rowspan="1" colspan="1">NM_001165878.1</td></tr><tr><td align="left" rowspan="1" colspan="1">IL&#x02010;18</td><td align="left" rowspan="1" colspan="1">240</td><td align="left" rowspan="1" colspan="1">GAG GAT ATG CCC GAT TCT GA</td><td align="left" rowspan="1" colspan="1">ATC ATG GCC TGG AAC ACT TC</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">NM_001003169.1</td></tr><tr><td align="left" rowspan="1" colspan="1">IL&#x02010;1&#x003b2;</td><td align="left" rowspan="1" colspan="1">440</td><td align="left" rowspan="1" colspan="1">GCA GTA CCC GAA CTC ACC AG</td><td align="left" rowspan="1" colspan="1">ACA TTT TCC CCA TTG AGG TG</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">NM_001037971.1</td></tr><tr><td align="left" rowspan="1" colspan="1">IL&#x02010;2</td><td align="left" rowspan="1" colspan="1">243</td><td align="left" rowspan="1" colspan="1">TCGCACTGACGCTTGTACTT</td><td align="left" rowspan="1" colspan="1">GCACTTCCTCCAGGTTTTTG</td><td align="left" rowspan="1" colspan="1">58.4</td><td align="left" rowspan="1" colspan="1">NM_001003305.1</td></tr><tr><td align="left" rowspan="1" colspan="1">IL&#x02010;22</td><td align="left" rowspan="1" colspan="1">254</td><td align="left" rowspan="1" colspan="1">TCCAGCAGCCCTATATCACC</td><td align="left" rowspan="1" colspan="1">TTGGCTTAGCTTGTTGCTGA</td><td align="left" rowspan="1" colspan="1">60.2</td><td align="left" rowspan="1" colspan="1">XM_538274.2</td></tr><tr><td align="left" rowspan="1" colspan="1">IL&#x02010;23p19</td><td align="left" rowspan="1" colspan="1">198</td><td align="left" rowspan="1" colspan="1">ATGGGACATGTGGACCTACC</td><td align="left" rowspan="1" colspan="1">TAGAGAAGGCTCCCCTGTGA</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">XM_538231.3</td></tr><tr><td align="left" rowspan="1" colspan="1">IL&#x02010;4</td><td align="left" rowspan="1" colspan="1">289</td><td align="left" rowspan="1" colspan="1">CTCACCTCCCAACTGATTCC</td><td align="left" rowspan="1" colspan="1">TGCTGCTGAGGTTCCTGTAG</td><td align="left" rowspan="1" colspan="1">56.4</td><td align="left" rowspan="1" colspan="1">NM_001003159.1</td></tr><tr><td align="left" rowspan="1" colspan="1">NLRP3</td><td align="left" rowspan="1" colspan="1">207</td><td align="left" rowspan="1" colspan="1">GCA ATG CTC TTG GAG ACA CA</td><td align="left" rowspan="1" colspan="1">AGA GCA GCA TGA CCC CTA GA</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">XM_843284.2</td></tr><tr><td align="left" rowspan="1" colspan="1">PPARy</td><td align="left" rowspan="1" colspan="1">413</td><td align="left" rowspan="1" colspan="1">GGATTTCTCCAGCATTTCCA</td><td align="left" rowspan="1" colspan="1">TATGAGACATCCCCACAGCA</td><td align="left" rowspan="1" colspan="1">59</td><td align="left" rowspan="1" colspan="1">NM_001024632.2</td></tr><tr><td align="left" rowspan="1" colspan="1">RORC</td><td align="left" rowspan="1" colspan="1">289</td><td align="left" rowspan="1" colspan="1">TGATGGAGACTGAGCACCTG</td><td align="left" rowspan="1" colspan="1">ACCAGAACCACTTCCATTGC</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">XM_540323.3</td></tr><tr><td align="left" rowspan="1" colspan="1">TFF1</td><td align="left" rowspan="1" colspan="1">161</td><td align="left" rowspan="1" colspan="1">GGA GCA CAG GGT GAT CTA CG</td><td align="left" rowspan="1" colspan="1">AAC AGC AGC CCT TGT CCT TA</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">NM_001002992.1</td></tr><tr><td align="left" rowspan="1" colspan="1">TFF3</td><td align="left" rowspan="1" colspan="1">105</td><td align="left" rowspan="1" colspan="1">ACGAACCTGTGCGAGGTG</td><td align="left" rowspan="1" colspan="1">GATGCTGGAGTCGAGCAG</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">NM_001002990.1</td></tr><tr><td align="left" rowspan="1" colspan="1">TGF&#x003b2;</td><td align="left" rowspan="1" colspan="1">609</td><td align="left" rowspan="1" colspan="1">GCATGTGGAGCTGTACCAGA</td><td align="left" rowspan="1" colspan="1">TAGTACACGATGGGCAGTGG</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">NM_001003309.1</td></tr><tr><td align="left" rowspan="1" colspan="1">TLR2</td><td align="left" rowspan="1" colspan="1">263</td><td align="left" rowspan="1" colspan="1">AGTGGCCAGAAAAGCTGAAA</td><td align="left" rowspan="1" colspan="1">ATCCAGTTGCTCCTTCGAGA</td><td align="left" rowspan="1" colspan="1">54.3</td><td align="left" rowspan="1" colspan="1">NM_001005264.2</td></tr><tr><td align="left" rowspan="1" colspan="1">TLR4</td><td align="left" rowspan="1" colspan="1">200</td><td align="left" rowspan="1" colspan="1">ATTCCTTTCCGGACAACTCC</td><td align="left" rowspan="1" colspan="1">CTGGAGGGAGAGGAGAGGTT</td><td align="left" rowspan="1" colspan="1">54.3</td><td align="left" rowspan="1" colspan="1">NM_001002950.2</td></tr><tr><td align="left" rowspan="1" colspan="1">TLR5</td><td align="left" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">TGGGCGAGCTCTATGACTCT</td><td align="left" rowspan="1" colspan="1">CTGAACGTCTGGTCCTGGAT</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">NM_001197176.1</td></tr><tr><td align="left" rowspan="1" colspan="1">TLR9</td><td align="left" rowspan="1" colspan="1">327</td><td align="left" rowspan="1" colspan="1">GCCTGGAGTACCTGCTCTTG</td><td align="left" rowspan="1" colspan="1">AGGCTTTGGTTTTGGTGATG</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">NM_001002998.1</td></tr><tr><td align="left" rowspan="1" colspan="1">TNF&#x003b1;</td><td align="left" rowspan="1" colspan="1">715</td><td align="left" rowspan="1" colspan="1">TTCTGCCTCAGCCTCTTCTC</td><td align="left" rowspan="1" colspan="1">GCCCTGAGCCCTTAATTCTC</td><td align="left" rowspan="1" colspan="1">60.2</td><td align="left" rowspan="1" colspan="1">NM_001003244.4</td></tr><tr><td align="left" rowspan="1" colspan="1">GAPDH<xref ref-type="fn" rid="jvim12563-note-0004">a</xref>
</td><td align="left" rowspan="1" colspan="1">194</td><td align="left" rowspan="1" colspan="1">GGAGAAAGCTGCCAAATATG</td><td align="left" rowspan="1" colspan="1">ACCAGGAAATGAGCTTGACA</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">NM_001003142.1</td></tr><tr><td align="left" rowspan="1" colspan="1">GUSB<xref ref-type="fn" rid="jvim12563-note-0004">a</xref>
</td><td align="left" rowspan="1" colspan="1">140</td><td align="left" rowspan="1" colspan="1">CATGCTGGTCCAGAGCTACA</td><td align="left" rowspan="1" colspan="1">CAGGCTTCAGGAAGGAAGTG</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">NM_001003191.1</td></tr><tr><td align="left" rowspan="1" colspan="1">HMBS<xref ref-type="fn" rid="jvim12563-note-0004">a</xref>
</td><td align="left" rowspan="1" colspan="1">112</td><td align="left" rowspan="1" colspan="1">TCACCATCGGAGCCATCT</td><td align="left" rowspan="1" colspan="1">GTTCCCACCACGCTCTTC</td><td align="left" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">XM_546491.3</td></tr><tr><td align="left" rowspan="1" colspan="1">PPIA<xref ref-type="fn" rid="jvim12563-note-0004">a</xref>
</td><td align="left" rowspan="1" colspan="1">159</td><td align="left" rowspan="1" colspan="1">GGGGAGAAGTTTGATGACGA</td><td align="left" rowspan="1" colspan="1">GACCTTGCCAAAGACCACAT</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">XM_532723.3</td></tr><tr><td align="left" rowspan="1" colspan="1">RPL32<xref ref-type="fn" rid="jvim12563-note-0004">a</xref>
</td><td align="left" rowspan="1" colspan="1">186</td><td align="left" rowspan="1" colspan="1">CCTCAGACCTCTGGTGAAGC</td><td align="left" rowspan="1" colspan="1">TTCTTGTTGCTCCCGTAACC</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">NM_001252169.1</td></tr><tr><td align="left" rowspan="1" colspan="1">SDHA<xref ref-type="fn" rid="jvim12563-note-0004">a</xref>
</td><td align="left" rowspan="1" colspan="1">412</td><td align="left" rowspan="1" colspan="1">GGACAGAGCCTCAAGTTTGG</td><td align="left" rowspan="1" colspan="1">GGCATCCTTCCGTAATGA</td><td align="left" rowspan="1" colspan="1">56.3</td><td align="left" rowspan="1" colspan="1">XM_535807.3</td></tr><tr><td align="left" rowspan="1" colspan="1">TBP<xref ref-type="fn" rid="jvim12563-note-0004">a</xref>
</td><td align="left" rowspan="1" colspan="1">267</td><td align="left" rowspan="1" colspan="1">GGGACCGCAGCAGATTACTA</td><td align="left" rowspan="1" colspan="1">GCCATAAGGCATCATTGGAC</td><td align="left" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">XM_849432.2</td></tr><tr><td align="left" rowspan="1" colspan="1">ATP5B<xref ref-type="fn" rid="jvim12563-note-0005">b</xref>
</td><td align="left" rowspan="1" colspan="1">196</td><td align="left" rowspan="1" colspan="1">AGCCCATGGTGGTTACTCTG</td><td align="left" rowspan="1" colspan="1">GGCAACAGTCAGTCCAGTCA</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">XM_531639.3</td></tr><tr><td align="left" rowspan="1" colspan="1">B2M<xref ref-type="fn" rid="jvim12563-note-0005">b</xref>
</td><td align="left" rowspan="1" colspan="1">99</td><td align="left" rowspan="1" colspan="1">ACGGAAAGGAGATGAAAGCA</td><td align="left" rowspan="1" colspan="1">CCTGCTCATTGGGAGTGAA</td><td align="left" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1">XM_003640047.1</td></tr><tr><td align="left" rowspan="1" colspan="1">HMBS<xref ref-type="fn" rid="jvim12563-note-0005">b</xref>
</td><td align="left" rowspan="1" colspan="1">112</td><td align="left" rowspan="1" colspan="1">TCACCATCGGAGCCATCT</td><td align="left" rowspan="1" colspan="1">GTTCCCACCACGCTCTTC</td><td align="left" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">XM_546491.3</td></tr><tr><td align="left" rowspan="1" colspan="1">PLA2R1<xref ref-type="fn" rid="jvim12563-note-0005">b</xref>
</td><td align="left" rowspan="1" colspan="1">231</td><td align="left" rowspan="1" colspan="1">GAAGCCAGCAATGTGTCTCA</td><td align="left" rowspan="1" colspan="1">TCACAAGTGCAGGAGGACAG</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">XM_545489.3</td></tr><tr><td align="left" rowspan="1" colspan="1">YES<xref ref-type="fn" rid="jvim12563-note-0005">b</xref>
</td><td align="left" rowspan="1" colspan="1">192</td><td align="left" rowspan="1" colspan="1">GTCTTTCCATGACGCCATTT</td><td align="left" rowspan="1" colspan="1">TTTGAAACCGTTCACCCTTC</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">NM_001003239.1</td></tr></tbody></table><table-wrap-foot><fn id="jvim12563-note-0004"><label>a</label><p>Reference genes for the duodenum.</p></fn><fn id="jvim12563-note-0005"><label>b</label><p>Reference genes for the colon.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec id="jvim12563-sec-0019"><title>Quantitative Polymerase Chain Reaction</title><p>qPCR reactions were carried out in triplicate at a total reaction volume of 20&#x000a0;&#x003bc;L, using a commercially available reagent mix<xref ref-type="fn" rid="jvim12563-note-1016">16</xref> and a primer concentration of 200&#x000a0;nM. Cycling steps were: 95&#x000b0;C for 5&#x000a0;min, then 40 cycles of 94&#x000b0;C for 15&#x000a0;s, 55&#x000b0;C for 10&#x000a0;s, 72&#x000b0;C for 10&#x000a0;s and 80&#x000b0;C for 5&#x000a0;s. Reaction efficiency was determined using 10&#x02010;fold dilutions (10<sup>7</sup> molecules &#x003bc;L<sup>&#x02212;1</sup> to 10<sup>1</sup> molecules &#x003bc;L<sup>&#x02212;1</sup>) of plasmids containing the cloned amplicon. Melting curves were generated to ensure a single amplicon had been produced. Averaged gene expression data for each sample were normalized against the geometric mean of the reference genes.<xref rid="jvim12563-bib-0025" ref-type="ref">25</xref>
</p></sec><sec id="jvim12563-sec-0020"><title>Genes of Interest</title><p>Several genes of the innate immune system interacting with bacteria (Toll&#x02010;like receptors<xref rid="jvim12563-bib-0026" ref-type="ref">26</xref>, <xref rid="jvim12563-bib-0027" ref-type="ref">27</xref> [TLRs] 2,4,5, and 9 as well as components of the inflammasome,<xref rid="jvim12563-bib-0028" ref-type="ref">28</xref> NLRP3, casp&#x02010;1, interleukin [IL]&#x02010;1&#x003b2; and IL&#x02010;18) and the adaptive immune response in the intestine were investigated. For the latter, several signature cytokines and transcription factors of different T helper lymphocyte (Th) cell lines were assessed. These included Th17 cells (IL&#x02010;17A, IL&#x02010;22, IL&#x02010;23p40, RORC),<xref rid="jvim12563-bib-0029" ref-type="ref">29</xref>, <xref rid="jvim12563-bib-0030" ref-type="ref">30</xref> Th1 cells (IL&#x02010;12p35, IL&#x02010;2, TNF&#x003b1;), Th2 cells (IFN&#x003b3; and IL&#x02010;4,<xref rid="jvim12563-bib-0031" ref-type="ref">31</xref> and Tregs (IL&#x02010;10 and TGF&#x003b2;).<xref rid="jvim12563-bib-0032" ref-type="ref">32</xref>
</p><p>Expression of the so&#x02010;called trefoil factors (TFF), genes associated with epithelial barrier function and repair,<xref rid="jvim12563-bib-0033" ref-type="ref">33</xref> also was assessed. The nuclear receptor PPAR&#x003b3;, usually responsible for blocking the transcription of inflammatory cytokines<xref rid="jvim12563-bib-0034" ref-type="ref">34</xref> and supposedly especially up&#x02010;regulated in intestinal epithelial cells by enterococci,<xref rid="jvim12563-bib-0035" ref-type="ref">35</xref> was investigated additionally.</p></sec></sec><sec id="jvim12563-sec-0021"><title>Dendrograms and Heatmaps from Gene Expression Data</title><p>To facilitate visualization of gene expression data and changes in gene expression among visits of the clinical trial, heatmaps were created using a statistical package<xref ref-type="fn" rid="jvim12563-note-1017">17</xref>.</p></sec><sec id="jvim12563-sec-0022"><title>Statistical Analyses</title><sec id="jvim12563-sec-0023"><title>Power Calculation</title><p>Clinical severity (as assessed by CCECAI) was selected as the primary outcome measure. Calculations were based on a type I error of 0.05 and a type II error of 0.1, which corresponds to a power of 90%. When assuming a difference (delta, &#x00394;) of 1.5 times the sd (&#x003c3;) to be medically relevant, the necessary number of animals in each group (treatment versus placebo) was determined to be n&#x000a0;=&#x000a0;11.</p></sec><sec id="jvim12563-sec-0024"><title>Analysis of Clincopathological, Histological and Gene Expression Data</title><p>Statistical analysis was performed using 2 commercially available software packages<xref ref-type="fn" rid="jvim12563-note-1018">18</xref>
<sup>,</sup>
<xref ref-type="fn" rid="jvim12563-note-1019">19</xref>. Normal distribution was assessed by inspection of histograms or D'Agostino and Pearson omnibus normality test. Subsequently, either parametric or non&#x02010;parametric tests were performed: A repeated measures model was used to assess the effect of the treatment interval (before versus after 6&#x000a0;weeks of treatment) and treatment type (EF versus placebo). Kruskal&#x02010;Wallis or <italic>t</italic>&#x02010;tests were performed to compare clinical and clinicopathological data, endoscopy and histology scores on visit 1 between treatment groups. Significance was set at <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05.</p></sec></sec></sec><sec id="jvim12563-sec-0025"><title>Results</title><sec id="jvim12563-sec-0026"><sec id="jvim12563-sec-0027"><title>Patients</title><p>A total of 51 possible cases were identified, 45 cases were recruited, and 28 completed visit 1. The remaining 17 dogs dropped out for several reasons: Owners changing their mind about participation in the study without giving specific reasons (n&#x000a0;=&#x000a0;5), owners not wanting endoscopy performed (n&#x000a0;=&#x000a0;3), additional medical problems were discovered before endoscopy was performed (n&#x000a0;=&#x000a0;3), with 1 dog developing pronounced neurological symptoms that were deemed more important than the chronic GIT signs, 1 dog collapsing after sedation for abdominal ultrasound examination and 1 dog being diagnosed with concurrent hypothyroidism, identification of other diseases causing the GIT signs (n&#x000a0;=&#x000a0;2, with 1 dog having metastatic gastric carcinoma and the other a pyloric sarcoma), owners not wanting to complete a 6&#x02010;weeks food trial (n&#x000a0;=&#x000a0;2), owners wanting to perform a food trial before endoscopy (n&#x000a0;=&#x000a0;1) and 1 dog that had an aggressive temperament. Of the remaining 28 dogs, 16 were withdrawn after visit 1 and did not complete the study. Reasons were: failure to respond to dietary treatment (n&#x000a0;=&#x000a0;6), owner not wishing to continue with the study without giving specific reasons (n&#x000a0;=&#x000a0;4), owner objecting to a second endoscopy procedure (n&#x000a0;=&#x000a0;2), diagnosis of another condition responsible for the clinical signs (n&#x000a0;=&#x000a0;2; 1 dog with colonic mucinous adenocarcinoma and 1 dog with pancreatitis), dog not eating the hydrolyzed protein diet (n&#x000a0;=&#x000a0;1), and 1 dog being too difficult to handle for a second period of hospitalization. Thus, a total of 12 dogs finished the clinical trial, including Labrador Retrievers (n&#x000a0;=&#x000a0;6), Golden Retrievers (n&#x000a0;=&#x000a0;2) and 1 dog each of the following breeds: Bracco Italiano, English Setter, Miniature Schnauzer and Standard Poodle. Six dogs were intact males, two dogs castrated males, and four dogs were spayed females. Their median age was 40&#x000a0;months (range, 12&#x02013;84&#x000a0;months). Seven dogs had been randomly assigned to receive the synbiotic product and 5 to receive placebo.</p></sec><sec id="jvim12563-sec-0028"><title>Clinical and Clinicopathological Data</title><p>The majority of dogs suffered from mixed small and large intestinal clinical signs (n&#x000a0;=&#x000a0;6), 3 had solely small intestinal clinical signs, 2 only chronic vomiting and 1 only large intestinal diarrhea. Clinical signs at visit 1 were scored mild to moderate with a median CCECAI of 4 (range, 1&#x02013;6) in the synbiotic group and 5 (range, 2&#x02013;7) in the placebo group, without a significant difference between groups. In addition, there was no effect of probiotic treatment on CCECAI at visit 2 or 3 compared to visit 1 (<italic>P</italic>&#x000a0;=&#x000a0;0.72). For both groups combined, CCECAI was significantly decreased at visits 2 and 3 compared to visit 1 (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.001), but not between visits 2 and 3 (Fig&#x000a0;<xref rid="jvim12563-fig-0002" ref-type="fig">2</xref>).</p><fig fig-type="Figure" xml:lang="en" id="jvim12563-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Canine chronic enteropathy clinical acvtivity index (<styled-content style="fixed-case">CCECAI</styled-content>) in 12 dogs participating in the clinical trial at visit 1 (V1&#x000a0;=&#x000a0;before treatment), visit 2 (V2&#x000a0;=&#x000a0;2&#x000a0;weeks after start of treatment) and visit 3 (V3&#x000a0;=&#x000a0;6&#x000a0;weeks after start of treatment).</p></caption><graphic id="nlm-graphic-3" xlink:href="JVIM-29-533-g002"/></fig><p>There were no significant differences in hematological and biochemical variables (including TLI, cPL, folate and cobalamin) between treatment groups at visit 1. Serum folate concentrations showed a significant increase with treatment at visit 3 compared to visit 1 (<italic>P</italic>&#x000a0;=&#x000a0;0.012). In addition, there was a significant difference in serum folate concentrations between the 2 treatment groups at visit 3 (<italic>P</italic>&#x000a0;=&#x000a0;0.012): dogs treated with placebo had higher serum concentrations of folate (mean, 21.42&#x000a0;&#x003bc;g&#x000a0;L<sup>&#x02212;1</sup>; SD, 2.56&#x000a0;&#x003bc;g&#x000a0;L<sup>&#x02212;1</sup>) than dogs treated with the synbiotic (mean, 17.02&#x000a0;&#x003bc;g&#x000a0;L<sup>&#x02212;1</sup>; SD, 1.68&#x000a0;&#x003bc;g&#x000a0;L<sup>&#x02212;1</sup>).</p></sec><sec id="jvim12563-sec-0029"><title>Endoscopic Findings</title><p>Endoscopic WSAVA scores were low in all areas examined at the initial visit: esophagus median 0 (range, 0&#x02013;6), stomach median 0 (range, 0&#x02013;16), duodenum median 1.5 (range, 0&#x02013;14) and colon median 0 (range, 0&#x02013;6). Endoscopy scores were even lower (but not significantly) at visit 3: esophagus median 0 (range, 0&#x02013;1), stomach median 0 (range, 0&#x02013;3), duodenum median 0 (range, 0&#x02013;6) and colon median 0 (range, 0&#x02013;1).</p></sec><sec id="jvim12563-sec-0030"><title>Histopathology</title><p>Median total WSAVA scoring of histopathological findings was 3 for the duodenum (range, 1&#x02013;5) and 2 (range, 1&#x02013;5) for the colon at visit 1. At visit 3, the median was 1 (range, 0&#x02013;8) and 3 (range, 0&#x02013;4) for the duodenum and colon, respectively. There was no significant difference in total scores among visits or between treatment groups for both sites. In the duodenum at visit 1, 7 dogs showed a mild increase in intra&#x02010;epithelial lymphocytes, 6 dogs showed mild generalized lymphoplasmacytic infiltration, and 2 dogs mild eosinophilic inflammation. Duodenal architectural changes were present in 8 dogs, and included villous stunting (n&#x000a0;=&#x000a0;5), mucosal fibrosis (n&#x000a0;=&#x000a0;3), lacteal distension (n&#x000a0;=&#x000a0;2), crypt distension (n&#x000a0;=&#x000a0;2) and epithelial injury (n&#x000a0;=&#x000a0;2). Mild lacteal dilatation was identified in 2 cases.</p><p>In the colon (visit 1), mild lymphoplasmacytic infiltration was present in six dogs, mild eosinophilic in two dogs, marked eosinophilic in one dog, and mild neutrophilic inflammation in two dogs. Architectural changes in the colon included crypt hyperplasia (n&#x000a0;=&#x000a0;6), crypt distention and distortion (n&#x000a0;=&#x000a0;4), fibrosis and atrophy (n&#x000a0;=&#x000a0;3) and mild surface epithelium injury (n&#x000a0;=&#x000a0;1). In 1 dog, the histology of the colon was reported as normal.</p></sec><sec id="jvim12563-sec-0031"><title>Gene Expression</title><p>In both duodenum and colon, TLR2 and TLR4 were more abundantly expressed than TLR5, and TLR9 was expressed at the lowest level (see Fig&#x000a0;<xref rid="jvim12563-fig-0003" ref-type="fig">3</xref>). Genes associated with the inflammasome generally were expressed at a much higher level in the colon than in the duodenum, especially casp&#x02010;1 (Fig&#x000a0;<xref rid="jvim12563-fig-0004" ref-type="fig">4</xref>).</p><fig fig-type="Figure" xml:lang="en" id="jvim12563-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>
<styled-content style="fixed-case">TLR</styled-content> expression in the duodenum (panels A) and colon (panels B) of 12 dogs participating in the clinical trial. V1&#x000a0;=&#x000a0;pre&#x02010;treatment visit, V3&#x000a0;=&#x000a0;after 6&#x000a0;weeks of dietary treatment and either synbiotic (labelled A on the x&#x02010;axis) or placebo (labelled B on the x&#x02010;axis) administration.</p></caption><graphic id="nlm-graphic-5" xlink:href="JVIM-29-533-g003"/></fig><fig fig-type="Figure" xml:lang="en" id="jvim12563-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Expression of genes related to the inflammasome in the duodenum (panels A) and colon (panels B) of 12 dogs participating in the clinical trial. V1&#x000a0;=&#x000a0;pre&#x02010;treatment visit, V3&#x000a0;=&#x000a0;after 6&#x000a0;weeks of dietary treatment and either synbiotic (labelled A on the x&#x02010;axis) or placebo (labelled B on the x&#x02010;axis) administration.</p></caption><graphic id="nlm-graphic-7" xlink:href="JVIM-29-533-g004"/></fig><p>There was no expression of IL&#x02010;17A in any duodenal sample, although RORC was expressed at a moderate level (Fig&#x000a0;<xref rid="jvim12563-fig-0005" ref-type="fig">5</xref>). In the colon, IL&#x02010;17A gene expression was detectable, but still negligible. Moderate levels of IL&#x02010;22 and IL&#x02010;23p19 and high levels of RORC mRNA expression were present in the colon (see Fig&#x000a0;<xref rid="jvim12563-fig-0006" ref-type="fig">6</xref>).</p><fig fig-type="Figure" xml:lang="en" id="jvim12563-fig-0005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Relative gene expression of cytokines related to differen T helper cell lines in the duodenum of dogs with chronic enteropathy participating in the clinical trial. The upper panel shows factors related to Th17 cells (<styled-content style="fixed-case">IL</styled-content>&#x02010;[Interleukin] 22, <styled-content style="fixed-case">IL</styled-content>&#x02010;23p35 and the transcription factor <styled-content style="fixed-case">RORC</styled-content>), the middle panel Th1 (<styled-content style="fixed-case">IL</styled-content>&#x02010;2, <styled-content style="fixed-case">IL</styled-content>&#x02010;12p35) and Th2 (<styled-content style="fixed-case">IFN</styled-content>&#x003b3;, <styled-content style="fixed-case">IL</styled-content>&#x02010;4) cytokines, and the lower panel <styled-content style="fixed-case">TNF</styled-content>&#x003b1;, which can be classed as innate cytokine or Th1 related, as well as <styled-content style="fixed-case">IL</styled-content>&#x02010;10 and Transforming growth factor &#x003b2; (<styled-content style="fixed-case">TGF</styled-content>&#x003b2;) as representatives of cytokines produced by regulatory T cells. On the x&#x02010;axis groups represent different visits (V1&#x000a0;=&#x000a0;before treatement, V3&#x000a0;=&#x000a0;after 6&#x000a0;weeks of treatment) and different treatment groups: A&#x000a0;=&#x000a0;hydrolyzed protein diet plus synbiotic product containing Enterococcus faecium; B&#x000a0;=&#x000a0;hydrolyzed protein diet plus placebo.</p></caption><graphic id="nlm-graphic-9" xlink:href="JVIM-29-533-g005"/></fig><fig fig-type="Figure" xml:lang="en" id="jvim12563-fig-0006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Relative gene expression of cytokines related to differen T helper cell lines in the colon of dogs with chronic enteropathy participating in the clinical trial. The upper panel shows factors related to Th17 cells (<styled-content style="fixed-case">IL</styled-content>&#x02010;[Interleukin] 17, <styled-content style="fixed-case">IL</styled-content>&#x02010;22, <styled-content style="fixed-case">IL</styled-content>&#x02010;23p35 and the transcription factor <styled-content style="fixed-case">RORC</styled-content>), the middle panel Th1 (<styled-content style="fixed-case">IL</styled-content>&#x02010;2, <styled-content style="fixed-case">IL</styled-content>&#x02010;12p35) and Th2 (<styled-content style="fixed-case">IFN</styled-content>&#x003b3;, <styled-content style="fixed-case">IL</styled-content>&#x02010;4) cytokines, and the lower panel <styled-content style="fixed-case">TNF</styled-content>&#x003b1;, which can be classed as innate cytokine or Th1 related, as well as <styled-content style="fixed-case">IL</styled-content>&#x02010;10 and Transforming growth factor &#x003b2; (<styled-content style="fixed-case">TGF</styled-content>&#x003b2;) as representatives of cytokines produced by regulatory T cells. On the x&#x02010;axis groups represent different visits (V1&#x000a0;=&#x000a0;before treatement, V3&#x000a0;=&#x000a0;after 6&#x000a0;weeks of treatment) and different treatment groups: A&#x000a0;=&#x000a0;hydrolyzed protein diet plus synbiotic product containing Enterococcus faecium; B&#x000a0;=&#x000a0;hydrolyzed protein diet plus placebo.</p></caption><graphic id="nlm-graphic-11" xlink:href="JVIM-29-533-g006"/></fig><p>As observed for other genes, expression levels of Th1 and Th2 cell&#x02010;related cytokines generally were higher in the colon than in the duodenum. The IL&#x02010;12p35 subunit was most abundantly expressed across all samples, followed by IFNy and TNF&#x003b1;. IL&#x02010;2 was expressed at low levels and IL&#x02010;4 showed the lowest expression (see Figs&#x000a0;<xref rid="jvim12563-fig-0005" ref-type="fig">5</xref>, <xref rid="jvim12563-fig-0006" ref-type="fig">6</xref>).</p><p>Of the genes associated with Tregs, TGF&#x003b2; showed the highest expression levels, followed by IL&#x02010;10, whereas FoxP3 was undetectable (Figs&#x000a0;<xref rid="jvim12563-fig-0005" ref-type="fig">5</xref>, <xref rid="jvim12563-fig-0006" ref-type="fig">6</xref>).</p><p>TFF1 expression was very low in duodenal samples, whereas TFF3 was highly expressed. The nuclear receptor PPAR&#x003b3; showed decreased gene expression at visit 3 compared to visit 1 in the duodenum (possibly more pronounced in the placebo&#x02010;treated group than the synbiotic&#x02010;treated dogs), but these differences were not statistically significant.</p><p>For all of the examined genes, there was no significant difference in expression with regard to time (before versus after treatment) or treatment (synbiotic versus placebo).</p></sec><sec id="jvim12563-sec-0032"><title>Heatmaps of Gene Expression</title><p>When assessing all duodenal or colonic samples, there was no clear effect of visit or treatment on differences in gene expression, both by repeat linear mixed modeling including all gene expression data or by subjective analysis of the clustering created by the heatmaps and dendrograms (see Fig&#x000a0;<xref rid="jvim12563-fig-0007" ref-type="fig">7</xref>). Similarly, there was no effect of visit or treatment on differences in gene expression in the colon by linear mixed modeling, and the heatmap also showed no clustering (see Fig&#x000a0;<xref rid="jvim12563-fig-0007" ref-type="fig">7</xref>). Gene expression responses in both tissue types were very variable among individual dogs.</p><fig fig-type="Figure" xml:lang="en" id="jvim12563-fig-0007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Heatmap and dendrograms depicting the difference in duodenal (A) and colonic (B) gene expression before and after treatment of 12 dogs with food&#x02010;responsive chronic enteropathy. Examined genes are listed on the x&#x02010;axis, dog <styled-content style="fixed-case">ID</styled-content>s in numbers and with a reference to treatment (A&#x000a0;=&#x000a0;synbiotic; B&#x000a0;=&#x000a0;placebo) are shown on the y&#x02010;axis. Both clustering of genes and dogs was allowed in these heatmaps based on gene expression similarities. Red colour indicates an increase in gene expression from visit 1 (before treatment) to visit 3 (6&#x000a0;weeks after treatment), blue indicates a decrease as depicted by the colour key.</p></caption><graphic id="nlm-graphic-13" xlink:href="JVIM-29-533-g007"/></fig></sec></sec></sec><sec id="jvim12563-sec-0033"><title>Discussion</title><p>The objective of the current study was to test the <italic>in&#x000a0;vivo</italic> effects (clinical outcome and changes in gene expression in intestinal tissues) of the PO administration of a synbiotic containing the probiotic EF in dogs with FRD. Although the number of initially recruited dogs would have likely been sufficient to show a difference based on the power calculation, unfortunately, the drop&#x02010;out rate was considerable. Hence, no additional clinical benefit of the administration of the synbiotic could be demonstrated or excluded. Also, no significant differences in expression of the examined genes were observed between visit 1 and 3 or between treatment groups in the duodenum or colon.</p><p>The study population was consistent with the literature regarding breed distributaion and age of dogs with CE.<xref rid="jvim12563-bib-0005" ref-type="ref">5</xref>, <xref rid="jvim12563-bib-0036" ref-type="ref">36</xref>, <xref rid="jvim12563-bib-0037" ref-type="ref">37</xref> Especially, dogs with FRD seem to be substantially younger than dogs suffering from other forms of CE.<xref rid="jvim12563-bib-0001" ref-type="ref">1</xref>, <xref rid="jvim12563-bib-0038" ref-type="ref">38</xref>, <xref rid="jvim12563-bib-0039" ref-type="ref">39</xref> There was no significant correlation between CCECAI and histopathological scores, a finding that has been demonstrated before.<xref rid="jvim12563-bib-0036" ref-type="ref">36</xref>, <xref rid="jvim12563-bib-0038" ref-type="ref">38</xref> However, it is possible that the dietary trial was not conducted for a sufficient period of time for morphological changes to resolve.</p><p>Interestingly, in all dogs, serum folate concentrations increased above the reference range with dietary treatment alone. This was more pronounced in the placebo&#x02010;treated group than in the synbiotic group. Because exocrine pancreatic insufficiency had been eliminated in these dogs, this finding could be indicative of a change in bacterial composition induced by the dietary intervention, which could have been ameliorated by probiotic treatment. Complementary investigations into the composition of the intestinal microbiome before treatment unfortunately was not performed. Macroscopic endoscopy scores and WSAVA histology scores did not change significantly with treatment, which is consistent with the literature.<xref rid="jvim12563-bib-0001" ref-type="ref">1</xref>, <xref rid="jvim12563-bib-0036" ref-type="ref">36</xref>, <xref rid="jvim12563-bib-0040" ref-type="ref">40</xref>, <xref rid="jvim12563-bib-0041" ref-type="ref">41</xref>
</p><p>The gene expression study showed that certain receptors of the innate immune system are differentially expressed in the canine intestine (TLR2 and 4 are more abundant than TLR5 and 9). This, as well as the fact that TFF1 is expressed at low levels, whereas TFF3 is abundantly present, has been reported before.<xref rid="jvim12563-bib-0039" ref-type="ref">39</xref>, <xref rid="jvim12563-bib-0042" ref-type="ref">42</xref>, <xref rid="jvim12563-bib-0043" ref-type="ref">43</xref>, <xref rid="jvim12563-bib-0044" ref-type="ref">44</xref> The general notion that there is no Th cell lineage&#x02010;associated cytokine bias in biopsies from dogs with FRD also could be confirmed<xref rid="jvim12563-bib-0045" ref-type="ref">45</xref> and was shown to be true for both the duodenum and the colon.</p><p>Most genes investigated were expressed at a higher level in the colonic mucosa compared to the duodenum. This is unlikely due to a better preservation or quality of colonic samples, because RNA quality and quantity were assessed for all biopsies and quantification of gene expression was performed relative to several reference genes that were assessed for their stability across samples. The increased gene expression levels in the large intestine could be associated with the larger number of bacteria present in the lumen compared to numbers in the small intestine. However, this also did not change with treatment for FRD or probiotic supplementation.</p><p>Limitations of the study included the fact that (despite all efforts) it remained underpowered. Therefore, results regarding the clinical benefit of EF in canine CE, as well as possible effects on gene expression, must be interpreted with caution. The clinical trial was designed to only include dogs with FRD and not other forms of CE. Including more severely affected dogs (with ARD or SRD) needing a variety of treatments would have required even larger numbers of dogs in each treatment group and might have made it more difficult to assess clinical improvement. Even if the desired 11 dogs had been recruited per treatment group, the study might have been underpowered. The choice of the appropriate data set from the literature to use for a power calculation is challenging, because usually a decrease of clinical indices of approximately 75% is considered consistent with remission.<xref rid="jvim12563-bib-0046" ref-type="ref">46</xref> However, this has been demonstrated mostly in dogs with idiopathic IBD (i.e., SRD), which seem to have much higher disease activity compared to FRD dogs.<xref rid="jvim12563-bib-0001" ref-type="ref">1</xref> Because the expected probiotic effect was unknown, power calculation was difficult to conduct.</p><p>Also, the dose of EF chosen to be administered to the dogs of this clinical trial was recommended by the manufacturer (1&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>&#x000a0;CFU once daily). However, limited data are available to suggest the appropriate amount of that particular EF strain needed to induce clinical, immunological or microbiome alterations. Administration of 2&#x02013;3&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup>&#x000a0;CFU/day of a different EF strain resulted in its persistence in feces for 3&#x000a0;months after cessation of the treatment.<xref rid="jvim12563-bib-0019" ref-type="ref">19</xref> In addition, culture of feces before and after treatment with EF was not performed in this study, which potentially could have been used to ensure owner compliance of capsule administration. However, because EF can be part of the normal fecal flora and the probiotic strain cannot be differentiated from the naturally&#x02010;occurring EF strains, the additional benefit of fecal culture is questionable.</p><p>In conclusion, this study did not have enough power to enable a statement regarding a potential additional effect of EF (given as a synbiotic) on clinical signs or gene expression in intestinal biopsies in dogs with FRD within a time period of 6&#x000a0;weeks. More studies using a larger number of dogs or dogs with different forms of CE are needed to assess the benefit of probiotics in CE of dogs. Testing of different probiotic strains for their clinical or anti&#x02010;inflammatory properties in comparison with EF also should be considered.</p></sec></body><back><ack id="jvim12563-sec-0034"><title>Acknowledgments</title><p>The authors thank the owners of the dogs participating in this study for taking part, as well as the help of the staff of the Queen Mother Hospital for Animals and the Clinical Investigation Centre of the RVC for their support in recruiting cases and acquiring all necessary samples and data. Additional thanks go to Dr. Victoria Offord (Bioinformatics Unit of the RVC) for her help with using the statistical programme &#x0201c;R&#x0201d; and creating the heat maps. The study was supported by the BBSRC with a studentship with Probiotics International Ltd., Somerset, UK. The RVC manuscript approval number is CSS_00823.</p><p>
<italic>Conflict of Interest Declaration</italic>: Authors disclose no conflict of interest.</p><p>
<italic>Off&#x02010;label Antimicrobial Declaration</italic>: Authors declare no off&#x02010;label use of antimicrobials.</p></ack><fn-group id="jvim12563-ntgp-0004"><title>Footnotes</title><fn id="jvim12563-note-1001"><label>1</label><p>Synbiotic D&#x02010;C; Probiotics International/ Protexin, Somerset, UK</p></fn><fn id="jvim12563-note-1002"><label>2</label><p>Microsoft Office, Excel, Microsoft Cooperation, Redmond, USA</p></fn><fn id="jvim12563-note-1003"><label>3</label><p>Purina Veterinary Diet canine HA Hypo Allergenic, Purina, Nestle, York, UK</p></fn><fn id="jvim12563-note-1004"><label>4</label><p>RNAlater (Ambion, UK)</p></fn><fn id="jvim12563-note-1005"><label>5</label><p>Qiagen (Manchester, UK)</p></fn><fn id="jvim12563-note-1006"><label>6</label><p>Mixer Mill MM300 tissue grinder (Retch, Leeds, UK)</p></fn><fn id="jvim12563-note-1007"><label>7</label><p>RNeasy micro kit (Qiagen)</p></fn><fn id="jvim12563-note-1008"><label>8</label><p>Eukaryote Total RNA Nano chip, Agilent Bioanalyzer, Agilent Technologies, Wokingham, UK)</p></fn><fn id="jvim12563-note-1009"><label>9</label><p>iScript cDNA synthesis kit (Bio&#x02010;Rad, Hemel Hampstead, UK)</p></fn><fn id="jvim12563-note-1010"><label>10</label><p>qBase/GeNorm software (Biogazelle, Gent, Belgium)</p></fn><fn id="jvim12563-note-1011"><label>11</label><p>PrimerDesign Ltd., Southampton, UK)</p></fn><fn id="jvim12563-note-1012"><label>12</label><p>Immolase polymerase, Bioline, London, UK)</p></fn><fn id="jvim12563-note-1013"><label>13</label><p>Wizard SV Gel and PCR clean&#x02010;up system (Promega)</p></fn><fn id="jvim12563-note-1014"><label>14</label><p>pGemT&#x02010;Easy vector (Promega)</p></fn><fn id="jvim12563-note-1015"><label>15</label><p>Source Bioscience, Cambridge, UK</p></fn><fn id="jvim12563-note-1016"><label>16</label><p>SsoFast Evagreen Supermix (Bio&#x02010;Rad, Hemel Hampstead, UK)</p></fn><fn id="jvim12563-note-1017"><label>17</label><p>The R project for statistical computing; <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org">www.r-project.org</ext-link>; &#x0201c;gplots&#x0201d; package; function heatmap.2</p></fn><fn id="jvim12563-note-1018"><label>18</label><p>SPSS (IBM SPSS statistics, version 19.0)</p></fn><fn id="jvim12563-note-1019"><label>19</label><p>Graph Pad Prism Version 5 (Graph Pad Software Inc., La Jolla, California, USA)</p></fn></fn-group><ref-list content-type="cited-references" id="jvim12563-bibl-0001"><title>References</title><ref id="jvim12563-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jvim12563-cit-0001">
<string-name>
<surname>Allenspach</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wieland</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Gr&#x000f6;ne</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gaschen</surname>
<given-names>F</given-names>
</string-name>. <article-title>Chronic enteropathies in dogs: evaluation of risk factors for negative outcome</article-title>. <source>J Vet Intern Med</source>
<year>2007</year>;<volume>21</volume>:<fpage>700</fpage>&#x02013;<lpage>708</lpage>.<pub-id pub-id-type="pmid">17708389</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jvim12563-cit-0002">
<string-name>
<surname>Jergens</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Moore</surname>
<given-names>FM</given-names>
</string-name>, <string-name>
<surname>Haynes</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Miles</surname>
<given-names>KG</given-names>
</string-name>. <article-title>Idiopathic inflammatory bowel disease in dogs and cats: 84 cases (1987&#x02013;1990)</article-title>. <source>J Am Vet Med Assoc</source>
<year>1992</year>;<volume>201</volume>:<fpage>1603</fpage>&#x02013;<lpage>1608</lpage>.<pub-id pub-id-type="pmid">1289345</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jvim12563-cit-0003">
<string-name>
<surname>German</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Hall</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Day</surname>
<given-names>MJ</given-names>
</string-name>. <article-title>Chronic intestinal inflammation and intestinal disease in dogs</article-title>. <source>J Vet Intern Med</source>
<year>2003</year>;<volume>17</volume>:<fpage>8</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">12564722</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jvim12563-cit-0004">
<string-name>
<surname>Suchodolski</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Xenoulis</surname>
<given-names>PG</given-names>
</string-name>, <string-name>
<surname>Paddock</surname>
<given-names>CG</given-names>
</string-name>, et&#x000a0;al. <article-title>Molecular analysis of the bacterial microbiota in duodenal biopsies from dogs with idiopathic inflammatory bowel disease</article-title>. <source>Vet Microbiol</source>
<year>2010</year>;<volume>142</volume>:<fpage>394</fpage>&#x02013;<lpage>400</lpage>.<pub-id pub-id-type="pmid">19959301</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jvim12563-cit-0005">
<string-name>
<surname>Suchodolski</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Markel</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Garcia&#x02010;Mazcorro</surname>
<given-names>JF</given-names>
</string-name>, et&#x000a0;al. <article-title>The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease</article-title>. <source>PLoS ONE</source>
<year>2012</year>;<volume>7</volume>:<fpage>e51907</fpage>.<pub-id pub-id-type="pmid">23300577</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jvim12563-cit-0006">
<string-name>
<surname>Xenoulis</surname>
<given-names>PG</given-names>
</string-name>, <string-name>
<surname>Palculict</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Allenspach</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Molecular&#x02010;phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease</article-title>. <source>FEMS Microbiol Ecol</source>
<year>2008</year>;<volume>66</volume>:<fpage>579</fpage>&#x02013;<lpage>589</lpage>.<pub-id pub-id-type="pmid">18647355</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jvim12563-cit-0007">
<string-name>
<surname>van Baarlen</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Troost</surname>
<given-names>FJ</given-names>
</string-name>, <string-name>
<surname>van Hemert</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Differential NF&#x02010;kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2009</year>;<volume>106</volume>:<fpage>2371</fpage>&#x02013;<lpage>2376</lpage>.<pub-id pub-id-type="pmid">19190178</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jvim12563-cit-0008">
<string-name>
<surname>Di Caro</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tao</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Grillo</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa</article-title>. <source>Dig Liver Dis</source>
<year>2005</year>;<volume>37</volume>:<fpage>320</fpage>&#x02013;<lpage>329</lpage>.<pub-id pub-id-type="pmid">15843081</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jvim12563-cit-0009">
<string-name>
<surname>Foligne</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zoumpopoulou</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Dewulf</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>A key role of dendritic cells in probiotic functionality</article-title>. <source>PLoS ONE</source>
<year>2007</year>;<volume>2</volume>:<fpage>e313</fpage>.<pub-id pub-id-type="pmid">17375199</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jvim12563-cit-0010">
<string-name>
<surname>Thomas</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Versalovic</surname>
<given-names>J</given-names>
</string-name>. <article-title>Probiotics&#x02010;host communication: modulation of signaling pathways in the intestine</article-title>. <source>Gut Microbes</source>
<year>2010</year>;<volume>1</volume>:<fpage>148</fpage>&#x02013;<lpage>163</lpage>.<pub-id pub-id-type="pmid">20672012</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jvim12563-cit-0011">
<string-name>
<surname>Shida</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nanno</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nagata</surname>
<given-names>S</given-names>
</string-name>. <article-title>Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities</article-title>. <source>Gut Microbes</source>
<year>2011</year>;<volume>2</volume>:<fpage>109</fpage>&#x02013;<lpage>114</lpage>.<pub-id pub-id-type="pmid">21637028</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jvim12563-cit-0012">
<string-name>
<surname>Bellavia</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rappa</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Lo Bello</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6&#x02010;trinitrobenzenesulfonic acid treatment in mice</article-title>. <source>J Biol Regul Homeost Agents</source>
<year>2014</year>;<volume>28</volume>:<fpage>251</fpage>&#x02013;<lpage>261</lpage>.<pub-id pub-id-type="pmid">25001657</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jvim12563-cit-0013">
<string-name>
<surname>Jeon</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Kayama</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ueda</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Probiotic Bifidobacterium breve induces IL&#x02010;10&#x02010;producing Tr1 cells in the colon</article-title>. <source>PLoS Pathog</source>
<year>2012</year>;<volume>8</volume>:<fpage>e1002714</fpage>.<pub-id pub-id-type="pmid">22693446</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jvim12563-cit-0014">
<string-name>
<surname>Linskens</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Huijsdens</surname>
<given-names>XW</given-names>
</string-name>, <string-name>
<surname>Savelkoul</surname>
<given-names>PH</given-names>
</string-name>, et&#x000a0;al. <article-title>The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics</article-title>. <source>Scand J Gastroenterol Suppl</source>
<year>2001</year>;<volume>234</volume>:<fpage>29</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">11768558</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jvim12563-cit-0015">
<string-name>
<surname>Sauter</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Benyacoub</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Allenspach</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Effects of probiotic bacteria in dogs with food responsive diarrhoea treated with an elimination diet</article-title>. <source>J Anim Physiol Anim Nutr (Berl)</source>
<year>2006</year>;<volume>90</volume>:<fpage>269</fpage>&#x02013;<lpage>277</lpage>.<pub-id pub-id-type="pmid">16867072</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jvim12563-cit-0016">
<string-name>
<surname>Rossi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pengo</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Caldin</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease</article-title>. <source>PLoS ONE</source>
<year>2014</year>;<volume>9</volume>:<fpage>e94699</fpage>.<pub-id pub-id-type="pmid">24722235</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jvim12563-cit-0017">
<string-name>
<surname>Sokol</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Pigneur</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Watterlot</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Faecalibacterium prausnitzii is an anti&#x02010;inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2008</year>;<volume>105</volume>:<fpage>16731</fpage>&#x02013;<lpage>16736</lpage>.<pub-id pub-id-type="pmid">18936492</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jvim12563-cit-0018">
<string-name>
<surname>Marcin&#x000e1;kov&#x000e1;</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Klingberg</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Laukov&#x000e1;</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Budde</surname>
<given-names>BB</given-names>
</string-name>. <article-title>The effect of pH, bile and calcium on the adhesion ability of probiotic enterococci of animal origin to the porcine jejunal epithelial cell line IPEC&#x02010;J2</article-title>. <source>Anaerobe</source>
<year>2010</year>;<volume>16</volume>:<fpage>120</fpage>&#x02013;<lpage>124</lpage>.<pub-id pub-id-type="pmid">19446648</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jvim12563-cit-0019">
<string-name>
<surname>Marcin&#x000e1;kov&#x000e1;</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Simonov&#x000e1;</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Strompfov&#x000e1;</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Laukov&#x000e1;</surname>
<given-names>A</given-names>
</string-name>. <article-title>Oral application of Enterococcus faecium strain EE3 in healthy dogs</article-title>. <source>Folia Microbiol. (Praha)</source>
<year>2006</year>;<volume>51</volume>:<fpage>239</fpage>&#x02013;<lpage>242</lpage>.<pub-id pub-id-type="pmid">17004657</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jvim12563-cit-0020">
<string-name>
<surname>Washabau</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Day</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Willard</surname>
<given-names>MD</given-names>
</string-name>, et&#x000a0;al. <article-title>Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals</article-title>. <source>J Vet Intern Med</source>
<year>2010</year>;<volume>24</volume>:<fpage>10</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">20391635</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jvim12563-cit-0021">
<string-name>
<surname>Day</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Bilzer</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mansell</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group</article-title>. <source>J Comp Pathol</source>
<year>2008</year>;<volume>138</volume>(<issue>Suppl 1</issue>):<fpage>S1</fpage>&#x02013;<lpage>S43</lpage>.<pub-id pub-id-type="pmid">18336828</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jvim12563-cit-0022">
<string-name>
<surname>Procoli</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>M&#x000f5;tsk&#x000fc;la</surname>
<given-names>PF</given-names>
</string-name>, <string-name>
<surname>Keyte</surname>
<given-names>SV</given-names>
</string-name>, et&#x000a0;al. <article-title>Comparison of histopathologic findings in duodenal and ileal endoscopic biopsies in dogs with chronic small intestinal enteropathies</article-title>. <source>J Vet Intern Med</source>
<year>2013</year>;<volume>27</volume>:<fpage>268</fpage>&#x02013;<lpage>274</lpage>.<pub-id pub-id-type="pmid">23398168</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jvim12563-cit-0023">
<string-name>
<surname>Schmitz</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Henrich</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Neiger</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>Stimulation of duodenal biopsies and whole blood from dogs with food&#x02010;responsive chronic enteropathy and healthy dogs with toll&#x02010;like receptor ligands and probiotic <italic>Enterococcus faecium</italic>
</article-title>. <source>Scand J Immunol</source>
<year>2014</year>;<volume>80</volume>:<fpage>85</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">24813376</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jvim12563-cit-0024">
<string-name>
<surname>Rozen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Skaletsky</surname>
<given-names>H</given-names>
</string-name>. <article-title>Primer3 on the WWW for general users and for biologist programmers</article-title>. <source>Methods Mol Biol</source>
<year>2000</year>;<volume>132</volume>:<fpage>365</fpage>&#x02013;<lpage>386</lpage>.<pub-id pub-id-type="pmid">10547847</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jvim12563-cit-0025">
<string-name>
<surname>Vandesompele</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>de Preter</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Pattyn</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Accurate normalization of real&#x02010;time quantitative RT&#x02010;PCR data by geometric averaging of multiple internal control genes</article-title>. <source>Genome Biol</source>
<year>2002</year>;<volume>3</volume>:<fpage>RESEARCH0034</fpage>.<pub-id pub-id-type="pmid">12184808</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jvim12563-cit-0026">
<string-name>
<surname>Abreu</surname>
<given-names>MT</given-names>
</string-name>. <article-title>Toll&#x02010;like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function</article-title>. <source>Nat Rev Immunol</source>
<year>2010</year>;<volume>10</volume>:<fpage>133</fpage>&#x02013;<lpage>141</lpage>.</mixed-citation></ref><ref id="jvim12563-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="jvim12563-cit-0027">
<string-name>
<surname>Tyrer</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Foxwell</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Cripps</surname>
<given-names>AW</given-names>
</string-name>, et&#x000a0;al. <article-title>Microbial pattern recognition receptors mediate M&#x02010;cell uptake of a gram negative bacterium</article-title>. <source>Infect Immun</source>
<year>2006</year>;<volume>74</volume>:<fpage>625</fpage>&#x02013;<lpage>631</lpage>.<pub-id pub-id-type="pmid">16369019</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="jvim12563-cit-0028">
<string-name>
<surname>Cario</surname>
<given-names>E</given-names>
</string-name>. <article-title>Heads up! How the intestinel epithelium safeguards mucosal barrier immunity through the inflammasome and beyond</article-title>. <source>Curr Opin Gastroenterol</source>
<year>2010</year>;<volume>26</volume>:<fpage>583</fpage>&#x02013;<lpage>590</lpage>.<pub-id pub-id-type="pmid">20664345</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="jvim12563-cit-0029">
<string-name>
<surname>Hirota</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Veldhoen</surname>
<given-names>M</given-names>
</string-name>. <article-title>Development, regulation and functional capacities of Th17 cells</article-title>. <source>Semin Immunopathol</source>
<year>2010</year>;<volume>32</volume>:<fpage>3</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">20107806</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="jvim12563-cit-0030">
<string-name>
<surname>Kanai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mikanmi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sujuno</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>RORyt&#x02010;dependent IL&#x02010;17A&#x02010;producing cells in the pathogenesis of intestinal inflammation</article-title>. <source>Mucosal Immunol</source>
<year>2012</year>;<volume>5</volume>:<fpage>240</fpage>&#x02013;<lpage>247</lpage>.<pub-id pub-id-type="pmid">22354322</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jvim12563-cit-0031">
<string-name>
<surname>Mosmann</surname>
<given-names>TR</given-names>
</string-name>, <string-name>
<surname>Coffman</surname>
<given-names>RL</given-names>
</string-name>. <article-title>Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties</article-title>. <source>Annu Rev Immunol</source>
<year>1989</year>;<volume>7</volume>:<fpage>145</fpage>&#x02013;<lpage>173</lpage>.<pub-id pub-id-type="pmid">2523712</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="jvim12563-cit-0032">
<string-name>
<surname>Fontenot</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Gavin</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Rudensky</surname>
<given-names>AY</given-names>
</string-name>. <article-title>FoxP3 programs the development and function of CD4&#x000a0;+&#x000a0;CD25&#x000a0;+&#x000a0; regulatory T&#x02010;cells</article-title>. <source>Nat Immunol</source>
<year>2003</year>;<volume>4</volume>:<fpage>330</fpage>&#x02013;<lpage>336</lpage>.<pub-id pub-id-type="pmid">12612578</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="jvim12563-cit-0033">
<string-name>
<surname>Thim</surname>
<given-names>L</given-names>
</string-name>. <article-title>Trefoil peptides: from structure to function</article-title>. <source>Cell Mol Life Sci</source>
<year>1997</year>;<volume>53</volume>:<fpage>888</fpage>&#x02013;<lpage>903</lpage>.<pub-id pub-id-type="pmid">9447240</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="jvim12563-cit-0034">
<string-name>
<surname>Wahli</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Michalik</surname>
<given-names>L</given-names>
</string-name>. <article-title>PPARs at the crossroads of lipid signalling and inflammation</article-title>. <source>Trends Endocrinol Metab</source>
<year>2012</year>;<volume>23</volume>:<fpage>351</fpage>&#x02013;<lpage>363</lpage>.<pub-id pub-id-type="pmid">22704720</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="jvim12563-cit-0035">
<string-name>
<surname>Are</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Aronsson</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Enterococcus faecalis from newborn babies regulates endogenous PPARgamma activity and IL&#x02010;10 levels in colonic epithelial cells</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2008</year>;<volume>106</volume>:<fpage>1943</fpage>&#x02013;<lpage>1948</lpage>.<pub-id pub-id-type="pmid">18234854</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="jvim12563-cit-0036">
<string-name>
<surname>Schreiner</surname>
<given-names>NMS</given-names>
</string-name>, <string-name>
<surname>Gaschen</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Gr&#x000f6;ne</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Clinical signs, histology, and CD3&#x02010;positive cells before and after treatment of dogs with chronic enteropathies</article-title>. <source>J Vet Intern Med</source>
<year>2008</year>;<volume>22</volume>:<fpage>1079</fpage>&#x02013;<lpage>1083</lpage>.<pub-id pub-id-type="pmid">18673423</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="jvim12563-cit-0037">
<string-name>
<surname>Mandigers</surname>
<given-names>PJJ</given-names>
</string-name>, <string-name>
<surname>Biourge</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>van den Ingh</surname>
<given-names>TSGAM</given-names>
</string-name>, et&#x000a0;al. <article-title>A randomized, open&#x02010;label, positively&#x02010;controlled field trial of a hydrolyzed protein diet in dogs with chronic small bowel enteropathy</article-title>. <source>J Vet Intern Med</source>
<year>2010</year>;<volume>24</volume>:<fpage>1350</fpage>&#x02013;<lpage>1357</lpage>.<pub-id pub-id-type="pmid">21054541</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="jvim12563-cit-0038">
<string-name>
<surname>Walker</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Knuchel&#x02010;Takano</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>McCutchan</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>A comprehensive pathological survey of duodenal biopsies from dogs with diet&#x02010;responsive chronic enteropathy</article-title>. <source>J Vet Intern Med</source>
<year>2013</year>;<volume>27</volume>:<fpage>862</fpage>&#x02013;<lpage>874</lpage>.<pub-id pub-id-type="pmid">23663231</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="jvim12563-cit-0039">
<string-name>
<surname>Allenspach</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>House</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Evaluation of mucosal bacteria and histopathology, clinical disease activity and expression of Toll&#x02010;like receptors in German shepherd dogs with chronic enteropathies</article-title>. <source>Vet Microbiol</source>
<year>2010</year>;<volume>146</volume>:<fpage>326</fpage>&#x02013;<lpage>335</lpage>.<pub-id pub-id-type="pmid">20615633</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="jvim12563-cit-0040">
<string-name>
<surname>Luckschander</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Allenspach</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hall</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease</article-title>. <source>J Vet Intern Med</source>
<year>2006</year>;<volume>20</volume>:<fpage>221</fpage>&#x02013;<lpage>227</lpage>.<pub-id pub-id-type="pmid">16594575</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="jvim12563-cit-0041">
<string-name>
<surname>Gaschen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kircher</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>St&#x000fc;ssi</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Comparison of ultrasonographic findings with clinical activity index (CIBDAI) and diagnosis in dogs with chronic enteropathies</article-title>. <source>Vet Radiol Ultrasound</source>
<year>2008</year>;<volume>49</volume>:<fpage>656</fpage>&#x02013;<lpage>664</lpage>.</mixed-citation></ref><ref id="jvim12563-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="jvim12563-cit-0042">
<string-name>
<surname>McMahon</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>House</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Catchpole</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>Expression of Toll&#x02010;like receptor 2 in duodenal biopsies from dogs with inflammatory bowel disease is associated with severity of disease</article-title>. <source>Vet Immunol Immunopathol</source>
<year>2010</year>;<volume>135</volume>:<fpage>158</fpage>&#x02013;<lpage>163</lpage>.<pub-id pub-id-type="pmid">20034678</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="jvim12563-cit-0043">
<string-name>
<surname>Burgener</surname>
<given-names>IA</given-names>
</string-name>, <string-name>
<surname>K&#x000f6;nig</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Allenspach</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Upregulation of toll&#x02010;like receptors in chronic enteropathies in dogs</article-title>. <source>J Vet Intern Med</source>
<year>2008</year>;<volume>22</volume>:<fpage>553</fpage>&#x02013;<lpage>560</lpage>.<pub-id pub-id-type="pmid">18466244</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="jvim12563-cit-0044">
<string-name>
<surname>Schmitz</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Werling</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Allenspach</surname>
<given-names>K</given-names>
</string-name>. <article-title>Expression of trefoil factor genes in the duodenum and colon of dogs with inflammatory bowel disease and healthy dogs</article-title>. <source>Vet Immunol Immunopathol</source>
<year>2013</year>;<volume>151</volume>:<fpage>168</fpage>&#x02013;<lpage>172</lpage>.<pub-id pub-id-type="pmid">23177627</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="jvim12563-cit-0045">
<string-name>
<surname>Jergens</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Sonea</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>O'Connor</surname>
<given-names>AM</given-names>
</string-name>, et&#x000a0;al. <article-title>Intestinal cytokine mRNA expression in canine inflammatory bowel disease: a meta&#x02010;analysis with critical appraisal</article-title>. <source>Comp Med</source>
<year>2009</year>;<volume>59</volume>:<fpage>153</fpage>&#x02013;<lpage>162</lpage>.<pub-id pub-id-type="pmid">19389307</pub-id></mixed-citation></ref><ref id="jvim12563-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="jvim12563-cit-0046">
<string-name>
<surname>Jergens</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Crandell</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Morrison</surname>
<given-names>JA</given-names>
</string-name>, et&#x000a0;al. <article-title>Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized&#x02010;controlled trial</article-title>. <source>J Vet Intern Med</source>
<year>2010</year>;<volume>24</volume>:<fpage>269</fpage>&#x02013;<lpage>277</lpage>.<pub-id pub-id-type="pmid">20051005</pub-id></mixed-citation></ref></ref-list></back></article>